Updated:
Healthcare Innovation
Healthcare Innovation’s growing community, comprised of its readers and event attendees, includes industry leaders and senior executives from across the...
Healthcare Innovation
Healthcare Innovation’s growing community, comprised of its readers and event attendees, includes industry leaders and senior executives from across the country such as CIOs, CISOs, CMIOs, CEOs, CFOs, physicians, IT directors, and many more thought leaders, game changers, and influencers who are driving change by shaping innovations that point the way to the future of healthcare.
General information
Firm type
Private Equity
Year founded
2012
Location
Region
Asia
Country
Japan
City
Tokyo
Corporate office
Tokyo, Japan
Sector focus
Frequently asked questions
What is Healthcare Innovation's investment focus?
Healthcare Innovation invests exclusively in the healthcare sector, spanning digital health, medical devices, and healthcare services. The firm targets companies from early-stage seed rounds through to late-stage expansion and pre-IPO financing, maintaining a stage-agnostic approach across its domestic Japanese market.
Does Healthcare Innovation operate as a single-family office or a traditional private equity firm?
Healthcare Innovation is structured as an asset manager with a private equity strategy. It is not publicly characterized as a single-family office or multi-family office, operating instead as a sector-specialist investment firm based in Tokyo.
How does Healthcare Innovation source its deals in Japan's healthcare sector?
Specific sourcing channels are not publicly detailed, but the firm's concentrated healthcare mandate and Tokyo headquarters position it to engage directly with Japan's medical device startups, health IT founders, and university-linked research spinouts. Specialist health investors in Japan typically leverage relationships with academic medical centers and regulatory consultants.
What is Healthcare Innovation's known posture on co-investments?
Public records do not confirm a formal co-investment program or club-deal structure. The firm's lean public profile and dedicated sector focus suggest it may evaluate co-investment on a deal-by-deal basis with strategic partners or institutional LPs familiar with Japanese healthcare.
Who are the principals running Healthcare Innovation?
No named principals — such as a founder, CEO, or CIO — are publicly identified through the firm's website, LinkedIn, or English-language financial press. The firm operates without broadcasting individual leadership biographies, typical of some privately held Japanese investment offices.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: